Blood

Published by: American Society of Hematology  

People

  1. Smith
    Smith
  2. Giralt
    Giralt
  3. Mailankody
    Mailankody
  4. Korde
    Korde
  5. Landgren
    Landgren
  6. Lesokhin
    Lesokhin
  7. Chung
    Chung
  8. Devlin
    Devlin
  9. Hassoun
    Hassoun
  10. Landau
    Landau

Groups

  1. Center for Hematologic Malignancies (13)
  2. Department of Medicine (13)
  3. Epidemiology and Biostatistics (13)
  4. Hematologic Malignancies Research (13)
  5. Hematologic Malignancies, Division of (13)
  6. Myeloma (13)
  7. Survivorship Research (13)
  8. Bone Marrow Transplant (12)
  9. Biostatistics Service (10)
  10. Sloan Kettering Institute Postdocs (10)
Search Within
  1. "Epidemiology and Biostatistics"
  2. "Survivorship Research"
  3. "Eric Smith"
Formats
  1. Meeting Abstract (13)
Groups
  1. Center for Hematologic Malignancies (13)
  2. Department of Medicine (13)
  3. Epidemiology and Biostatistics (13)
  4. Hematologic Malignancies Research (13)
  5. Hematologic Malignancies, Division of (13)
  6. Myeloma (13)

More Groups

People
  1. Eric Smith (13)
  2. Sergio Giralt (12)
  3. Sham Mailankody (12)
  4. Alexander Lesokhin (11)
  5. Carl Landgren (11)
  6. Neha Korde (11)

More People

Years
  1. 2020 (1)
  2. 2019 (4)
  3. 2018 (5)
  4. 2017 (1)
  5. 2016 (1)
  6. 2015 (1)
Publishers
  1. American Society of Hematology (13)

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term sustained minimal residual disease (MRD) negativity in patients with multiple myeloma treated with continuous lenalidomide maintenance therapy: A clinical and correlative phase 2 study
    Meeting Abstract

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U. A.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • VTE rates and safety analysis of newly diagnosed multiple myeloma patients receiving carfilzomib-lenalidomide-dexamethasone (KRD) with or without rivaroxaban prophylaxis
    Meeting Abstract

    Piedra, K. M.; Hassoun, H.; Buie, L. W.; Devlin, S. M.; Flynn, J.; Hultcrantz, M.; Lesokhin, A. M.; Lu, S. X.; Mailankody, S.; Shah, U. A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Long-term sustained minimal residual disease (MRD) negativity in multiple myeloma patients treated with lenalidomide maintenance therapy: A clinical and correlative phase 2 study
    Meeting Abstract

    Landgren, O.; Mastey, D.; Lesokhin, A. M.; Smith, E. L.; Shah, U. A.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Salcedo, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Hematological count recovery in patients undergoing treatment with chimeric antigen receptor T cells (CAR T)
    Meeting Abstract

    Jain, T.; Knezevic, A.; Pennisi, M.; Ruiz, J. D.; Devlin, S. M.; Maloy, M. A.; Halton, E.; Diamonte, C.; Scordo, M.; Sauter, C. S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy provides unprecedented MRD negativity rates in newly diagnosed multiple myeloma: A clinical and correlative phase 2 study
    Meeting Abstract

    Landgren, O.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Smith, E. L.; Shah, U. A.; Lu, S. X.; Mastey, D.; Salcedo, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Resource utilization early after chimeric antigen receptor (CAR) T cell infusion for hematologic malignancies
    Meeting Abstract

    Shah, G. L.; Park, J. H.; Sauter, C. S.; Duck, E.; Halton, E.; Palomba, M. L.; Batlevi, C. L.; Younes, A.; Geyer, M. B.; Smith, E. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • MRD-response driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m(2)) in combination with lenalidomide and dexamethasone
    Meeting Abstract

    Korde, N.; Mastey, D.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Smith, E. L.; Lendvai, N.; Hultcrantz, M.; Tavitian, E.; Salcedo, M.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Depth of response and outcomes in patients with multiple myeloma undergoing autologous stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Seier, K.; Devlin, S. M.; Chung, D. J.; Scordo, M.; Hultcrantz, M.; Korde, N.; Lendvai, N.; Lesokhin, A. M.; Mailankody, S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Treatment outcomes in monoclonal immunoglobulin deposition disease (MIDD): A two center experience
    Meeting Abstract

    Pianko, M. J.; Tiutan, T.; Flynn, J.; Devlin, S. M.; Jaffer-Sathick, I.; Rossi, A. C.; Salvatore, S. P.; Landau, H. J.; Lendvai, N.; Smith, E. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Capture rate of the adaptive next generation sequencing VDJ assay in multiple myeloma
    Meeting Abstract

    Hultcrantz, M.; Rustad, E. H.; Yellapantula, V.; Akhlaghi, T.; Jacob, A.; Patel, A.; Korde, N.; Mailankody, S.; Lendvai, N.; Lesokhin, A. M.; more...
    Blood (2018)

    Fulltext@MSK | Save

    • Blood – authorized name for:

    Name ISSN / ISBN Publisher
    Blood 0006-4971 American Society of Hematology
    Blood 00064971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 00064971 Unknown
    Blood 0006-4971 American Society of Hematology
    Blood 15280020 American Society of Hematology
    Blood 0006-4971 W.B. Saunders Co.
    Blood 1528-0020 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 15280020 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 00064971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology and American Society of Clinical Oncology
    Blood 0006-4971 American Society of Hematology
    Blood 15280020 Unknown
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 W.B. Saunders Co.
    Blood 1528-0020 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 00064971 2023
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology and American Society of Clinical Oncology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 1528-0020 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology